Otolaryngology · Glens Falls, NY
NPI
1427044262
Since 2005
Specialty
Otolaryngology
Code 207Y00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
2 Broad Street Plz, Adirondack ENT
Glens Falls, NY, 12801
Phone (518) 926-1380
Groups this clinician bills Medicare through
Medicare paid, 2024
$132K
3,895 services
Medicare patients, 2024
495
Average age 74
Drug cost, 2024
$155K
1,598 prescriptions
Company payments, 2025
$421
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard A Hughes Jr. was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 1,780 times for 22 patients. In total Richard A Hughes Jr. billed 3,895 services in 37 codes, and Medicare paid $132K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-02.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 1,780 | 22 | $0.11 | $187 |
| 99214 Office E&M - Established | Office | 350 | 252 | $94.59 | $33K |
| 31231 Nasal/Sinus Endoscopy | Office | 260 | 193 | $131.04 | $34K |
| 99213 Office E&M - Established | Office | 226 | 159 | $64.49 | $15K |
| 69210 Other Organ Systems | Office | 201 | 136 | $31.33 | $6,297 |
| 99204 Office E&M - New | Office | 103 | 103 | $121.83 | $13K |
| 77011 Conventional Radiation Treatment | Office | 48 | 47 | $166.15 | $7,975 |
| 69801 Other Organ Systems | Office | 28 | 11 | $178.74 | $5,005 |
| 69420 Other Organ Systems | Office | 15 | 14 | $165.93 | $2,489 |
| 70491 CT/CTA - Head and Neck | Office | 13 | 13 | $124.53 | $1,619 |
| 70480 CT/CTA - Head and Neck | Office | 11 | 11 | $93.18 | $1,025 |
By year: 2022 $36K for 1,153 services; 2023 $42K for 1,504 services; 2024 $132K for 3,895 services.
Medicare prescription drug claims, 2024
In 2024, the drug Richard A Hughes Jr. prescribed most often to Medicare patients was Azelastine Hcl, with 336 prescriptions and refills. In total Richard A Hughes Jr. wrote 1,598 Medicare prescriptions that cost $155K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azelastine Hcl Generic | 336 | 416 | 108 | $6,765 |
| Mometasone Furoate Generic | 208 | 274 | 88 | $14K |
| Ciprofloxacin-Dexamethasone Ciprofloxacin Hcl/Dexameth | 115 | 115 | 57 | $13K |
| Levocetirizine Dihydrochloride Generic | 109 | 175 | 31 | $828 |
| Fluticasone Propionate Generic | 80 | 116 | 30 | $1,010 |
| Olopatadine Hcl Generic | 72 | 107 | 28 | $7,565 |
| Desloratadine Generic | 66 | 140 | 26 | $2,950 |
| Ipratropium Bromide Generic | 60 | 84 | 30 | $1,731 |
| Omeprazole Generic | 55 | 71 | 18 | $419 |
| Montelukast Sodium Generic | 45 | 109 | 18 | $404 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 35 | 37 | 29 | $381 |
| Prednisone Generic | 32 | 32 | 29 | $95.1 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 23 | 23 | Under 11 | $15K |
| Triamterene-Hydrochlorothiazid Triamterene/Hydrochlorothiazid | 23 | 53 | Under 11 | $74.25 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 23 | 25 | 13 | $220 |
Brand drugs: 162 claims; generic drugs: 1,436 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard A Hughes Jr. $421 ($421 in general payments such as food, travel and fees) from 8 companies. The largest payer was ARS Pharmaceuticals Operations, Inc. with $186.
| Company | Payments | Amount |
|---|---|---|
| ARS Pharmaceuticals Operations, Inc. SPRY | 5 | $186 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $70.62 |
| Amgen Inc. AMGN | 2 | $52.01 |
| Genzyme Corporation SNY | 1 | $23.39 |
| Phathom Pharmaceuticals, Inc. PHAT | 2 | $22.96 |
| GlaxoSmithKline, LLC. GSK | 1 | $22.41 |
| Harmony Biosciences LLC HRMY | 1 | $22.41 |
| Neurent Medical Limited | 1 | $20.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.